Jan 07, 2016 13:00 pm UTC| Business
CAMBRIDGE, Mass., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Dimension Therapeutics, Inc. (NASDAQ:DMTX), a leading gene therapy company advancing novel, liver-directed treatments for diverse rare diseases, today announced the...
Peak Resorts Completes Acquisition of Hunter Mountain for $36.8 Million
Jan 07, 2016 13:00 pm UTC| Business
WILDWOOD, Mo., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Peak Resorts, Inc. (NASDAQ:SKIS), a leading owner and operator of high-quality, individually branded ski resorts in the U.S., today announced it has completed the...
Skullcandy Adds Legendary Snowboarder Travis Rice as Ambassador
Jan 07, 2016 13:00 pm UTC| Business
PARK CITY, Utah, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Skullcandy, Inc. (NASDAQ:SKUL), the original performance lifestyle audio brand, is thrilled to announce its newestaddition to the family—Travis Rice, one ofthe most...
REGENXBIO Provides Year-End 2015 Corporate Update
Jan 07, 2016 13:00 pm UTC| Business
Company begins 2016 in strong financial position, on track to advance multiple lead gene therapy product candidate programs into clinicRGX-501 IND for treatment of homozygous familial hypercholesterolemia is activeFive new...
Prothena Announces Pricing of Public Offering of 2,250,000 Ordinary Shares
Jan 07, 2016 13:00 pm UTC| Business
DUBLIN, Ireland, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein...
KemPharm Added to NASDAQ Biotechnology Index
Jan 07, 2016 13:00 pm UTC| Business
CORALVILLE, Iowa , Jan. 07, 2016 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, announced today that...
BeyondSpring Pharmaceuticals to Present at 8th Annual Biotech Showcase
Jan 07, 2016 13:00 pm UTC| Business
NEW YORK, Jan. 07, 2016 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies including a Phase III immuno-oncology...